Why the study?
Does the combined use of non-thoracotomy ICDs and endocardial pacemakers cause adverse device interactions such as detection inhibition of ventricular fibrillation?
Does the combined use of non-thoracotomy ICDs and endocardial pacemakers cause adverse device interactions such as detection inhibition of ventricular fibrillation?
Non-thoracotomy ICDs and endocardial pacemakers can be safely combined, provided careful testing is performed at implantation to detect and remedy device interactions.
No takes yet. Share an insight, caveat, or question.
Final lead optimization prevents VF detection inhibition; supports combined non-thoracotomy ICD-pacemaker use but leaves open long-term safety in larger cohorts.
Noguera et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: